Author

Li He

University of GeorgiaORCID 0000-0003-2289-4888Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Li He2 papers · Amgen (United States)

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

George Em KarniadakisiD· 1 shared K. Melissa HallowiD· 1 shared Lu LuiD· 1 shared Ming DaoiD· 1 shared Nazanin Ahmadi DaryakenariiD· 1 shared Pierre A. BuffetiD· 1 shared Qian YingiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

George Em KarniadakisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintOct 25, 2025

In Silico Post-screening of Anti-polymerization Agents to Treat Sickle Cell Disease

Qian Ying, Nazanin Ahmadi Daryakenari, K. Melissa Hallow…·George Em Karniadakis

This paper develops a computational platform to evaluate anti-sickling agents by integrating PK/PD models with RBC sickling kinetics, demonstrating its utility in predicting therapeutic efficacy and noncompliance outcomes for existing and potential drugs.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky